205 related articles for article (PubMed ID: 4275505)
21. Human immune response to Rauscher leukemia virus.
Hersh EM; Gutterman JU; Mavligit G; Gschwind CR; Hanna MG
Hamatol Bluttransfus; 1974; 14():119-28. PubMed ID: 4475656
[No Abstract] [Full Text] [Related]
22. The formation of stable E rosettes after neuraminidase treatment of either human peripheral blood lymphocytes or of sheep red blood cells.
Galili U; Schlesinger M
J Immunol; 1974 May; 112(5):1628-34. PubMed ID: 4818458
[No Abstract] [Full Text] [Related]
23. In vivo and in vitro assays of cellular immunity to human tumor antigens.
Herberman RB
Fed Proc; 1973 Feb; 32(2):160-4. PubMed ID: 4120197
[No Abstract] [Full Text] [Related]
24. Cytotoxicity of human rosette-forming blood lymphocytes on cultivated human tumor cells.
Wybran J; Hellström I; Hellström KE; Fudenberg HH
Int J Cancer; 1974 Apr; 13(4):515-21. PubMed ID: 4546321
[No Abstract] [Full Text] [Related]
25. Selective immunosuppression by drugs in balanced immune responses.
Heppner GH; Griswold DE; Di Lorenzo J; Poplin EA; Calabresi P
Fed Proc; 1974 Aug; 33(8):1882-5. PubMed ID: 4602113
[No Abstract] [Full Text] [Related]
26. [Cellular immunity in leukemia].
Osipov SG
Probl Gematol Pereliv Krovi; 1978 Aug; 23(8):36-41. PubMed ID: 80008
[No Abstract] [Full Text] [Related]
27. Cellular and humoral immunity in tumour bearing animals immunized with erythrocytes.
Donovan G; Dumitrescu R; Popp I; Maltezeanu G
Neoplasma; 1971; 18(3):241-9. PubMed ID: 5093945
[No Abstract] [Full Text] [Related]
28. Antibody dependent cellular cytotoxicity: cytotoxicity mediated by non t-lymphocytes.
Zighelboim J; Gale RP; Chiu A; Bonavida B; Ossorio RC; Fahey JL
Clin Immunol Immunopathol; 1974 Nov; 3(2):193-200. PubMed ID: 4548867
[No Abstract] [Full Text] [Related]
29. [Effect of rubomycin and carminomycin on the delayed hypersensitivity reaction in mice immunized with ram erythrocytes].
Vatin AE
Antibiotiki; 1981 Oct; 26(10):750-3. PubMed ID: 6975599
[TBL] [Abstract][Full Text] [Related]
30. [Immunotherapy].
Lejeune FJ; Bernheim JL; Vanwijck R
Acta Chir Belg; 1974 Mar; 73(2):265-93. PubMed ID: 4450923
[No Abstract] [Full Text] [Related]
31. Immunologic aspects of malignant tumors.
Ariyan S
Clin Plast Surg; 1979 Apr; 6(2):125-142. PubMed ID: 313868
[No Abstract] [Full Text] [Related]
32. [Delayed hypersensitivity as a result of successful chemotherapy of neoplasms].
Jedrzejczak WW
Wiad Lek; 1980 Apr; 33(7):547-53. PubMed ID: 6967240
[No Abstract] [Full Text] [Related]
33. Some recent developments in human tumour immunology.
The TH
Folia Med Neerl; 1972; 15(6):279-90. PubMed ID: 4565658
[No Abstract] [Full Text] [Related]
34. Cytotoxity of non-T versus T-lymphocytes from melanoma patients and healthy donors on short- and long-term cultured melanoma cells,
de Vries JE; Cornain S; Rumke P
Int J Cancer; 1974 Oct; 14(4):427-34. PubMed ID: 4549213
[No Abstract] [Full Text] [Related]
35. Cytotoxicity mediated by human lymphocyte-dependent antibody in a rapid assay with adherent target cells.
Yust I; Wunderlich JR; Mann DL; Buell DN
J Immunol; 1973 Jun; 110(6):1672-81. PubMed ID: 4712926
[No Abstract] [Full Text] [Related]
36. Combined detection of human T and B lymphocytes by rosette formation with sheep erythrocytes and zymosan-C3 complexes.
Mendes NF; Miki SS; Peixinho ZF
J Immunol; 1974 Aug; 113(2):531-6. PubMed ID: 4546446
[No Abstract] [Full Text] [Related]
37. Vaccine adjuvant systems containing monophosphoryl lipid A and QS21 induce strong and persistent humoral and T cell responses against hepatitis B surface antigen in healthy adult volunteers.
Vandepapelière P; Horsmans Y; Moris P; Van Mechelen M; Janssens M; Koutsoukos M; Van Belle P; Clement F; Hanon E; Wettendorff M; Garçon N; Leroux-Roels G
Vaccine; 2008 Mar; 26(10):1375-86. PubMed ID: 18272264
[TBL] [Abstract][Full Text] [Related]
38. Quality, affinity, and class A antibody produced after partial tolerance induction.
Liacopoulos P; Harel S; Efraim SB
Transplant Proc; 1972 Sep; 4(3):391-4. PubMed ID: 5080605
[No Abstract] [Full Text] [Related]
39. Enzymatic enhancement of cell-mediated cytotoxicity and antibody-dependent cell cytotoxicity.
Kedar E; Otiz de Landazuri M; Fahey JL
J Immunol; 1974 Jan; 112(1):26-36. PubMed ID: 4812174
[No Abstract] [Full Text] [Related]
40. [New data on experimental tumor immunology].
Schneeweiss U; Gummel H
Z Exp Chir; 1972; 5(2):66-80. PubMed ID: 4680973
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
